Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Generic drugmakers continue to navigate a challenging U.S. market defined by persistent price erosion, intense competition ...

The brand name of the drug is Ziac, manufactured by Glenmark Pharmaceuticals Inc., a major producer of both brand-name and ...

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Formularies continue to increase in complexity, and changes to those formularies are especially challenging for consumers to navigate.

The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Humana CEO Jim Rechtin and the Cost Plus Drugs founder reportedly spoke Thursday about ways to lower the cost of drugs.

Confused about Medicare Part D? Explore essential insights that clearly explain how it works, what it covers, and how to ...

Pharmacy benefit managers (PBMs) are back in the crosshairs. PBMs negotiate drug prices down on behalf of consumers and insurers – to the ire of ...

Activists urge India to waive clinical trial requirements for lenacapavir, as patent barriers threaten access to the vital ...